Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age
© Mutapi et al; licensee BioMed Central Ltd. 2007
Received: 05 March 2007
Accepted: 28 November 2007
Published: 28 November 2007
The rate of development of parasite-specific immune responses can be studied by following their age profiles in exposed and infected hosts. This study determined the cytokine-age profiles of Zimbabweans resident in a Schistosoma haematobium endemic area and further investigated the relationship between the cytokine responses and infection intensity.
Schistosome adult worm antigen-specific IFN-γ, IL-4, IL-5 and IL-10 cytokine responses elicited from whole blood cultures were studied in 190 Zimbabweans exposed to S. haematobium infection (aged 6 to 40 years old). The cytokines were measured using capture ELISAs and the data thus obtained together with S. haematobium egg count data from urine assays were analysed using a combination of parametric and nonparametric statistical approaches.
Age profiles of schistosome infection in the study population showed that infection rose to peak in childhood (11–12 years) followed by a sharp decline in infection intensity while prevalence fell more gradually. Mean infection intensity was 37 eggs/10 ml urine (SE 6.19 eggs/10 ml urine) while infection prevalence was 54.7%. Measurements of parasite-specific cytokine responses showed that IL-4, IL-5 and IL-10 but not IFN-γ followed distinct age-profiles. Parasite-specific IL-10 production developed early, peaking in the youngest age group and declining thereafter; while IL-4 and IL-5 responses were slower to develop with a later peak. High IL-10 producers were likely to be egg positive with IL-10 production increasing with increasing infection intensity. Furthermore people producing high levels of IL-10 produced little or no IL-5, suggesting that IL-10 may be involved in the regulation of IL-5 levels. IL-4 and IFN-γ did not show a significant relationship with infection status or intensity and were positively associated with each other.
Taken together, these results show that the IL-10 responses develop early compared to the IL-5 response and may be down-modulating immunopathological responses that occur during the early phase of infection. The results further support current suggestions that the Th1/Th2 dichotomy does not sufficiently explain susceptibility or resistance to schistosome infection.
Schistosomiasis is a major human parasitic disease caused by trematode parasites of the genus Schistosoma. Of the three major human schistosome species, S. haematobium, causing urinary schistosomiasis, is the most prevalent species in sub-Saharan Africa where it is responsible for a substantial amount of schistosome-associated pathology .
The role of acquired immunity in reducing schistosome infection intensity in human populations has been subject to intense analysis [2–7]. Schistosome immuno-epidemiology studies have shown that the development of antigen-specific immune responses is related to cumulative exposure to parasite antigens [8, 9] and that the rate of development of different components of these responses give distinct profiles across the host age range . These profiles have facilitated the identification of responses associated with protection to infection/re-infection. For example, anti-worm IgE levels were shown to increase with age in S. haematobium exposed/infected children in the Gambia, while infection intensity declined  and the combined change in IgA (declining) and IgG1 (rising) with age in Zimbabwean populations residing in S. haematobium endemic areas was associated with resistance to infection . Thus an understanding of the rate of development of parasite-specific immune responses derived from age profiles is useful in interpreting susceptibility and resistance to infection as well as the development of pathology. This is particularly important for the cellular responses, which determine the majority of effector functions and immune mediated schistosome pathology [13–15]. Detailed studies following the development of schistosome-specific cellular responses over a period of time have been conducted in the mouse model, but such studies have yet to be conducted in human schistosomiasis (see  for review). Given that differences occur in the immunology and immunopathology of murine and human schistosomiasis [16, 17], human studies are essential for a clearer definition of human schistosome immuno-epidemiology.
Mouse experimental schistosomiasis studies suggest that the development of effector Th1/Th2 and immuno-modulatory responses reflect the parasite's developmental stage (see  for review) so that Th1 responses predominate in the early acute phase followed by the emergence of Th2 responses (stimulated by egg antigens) and decrease in Th1 responses (down-modulated through an IL-10-dependent mechanism) . To date, detailed studies giving an indication of the time course of the development of cellular responses against the parasite have not been performed in human schistosomiasis. Thus this study aims to determine the cytokine-age profiles of Zimbabweans resident in S. haematobium endemic areas. The cytokines to be studied are IFN-γ, a marker for Th1 responses, IL-4 and IL-5, markers for Th2 responses, and IL-10, originally classified as both a Th1 and Th2 cytokine in humans  but now also seen as a marker for immuno-modulatory (including regulatory responses) [18, 20, 21].
The study also determines the relationship between these cytokine responses and infection intensity. Previous studies have suggested that anti-helminth immune responses fall into a clear Th1 (pro-inflammatory) and Th2 (anti-inflammatory) dichotomy with resistance to schistosome infection being associated with Th2 responses [22–25]. More recently there has been mounting evidence that unlike the intracellular pathogens such as Toxoplasma gondii and Leishmania major where there is a clear polarisation of the protective response to Th1, the relationship between the Th1/Th2 dichotomy to the development of acquired immunity against schistosomes and other helminths remains unclear ([26–30], see  for review). For example, we have previously shown that anti-egg Th1 and Th2 cytokine responses in S. haematobium infected/exposed Zimbabwean children did not show a clear pattern with infection intensity . In fact, the Th2 cytokines IL-4 and IL-5 gave contradictory results [32, 33]. Our studies and those of others have suggested that some of the differences reported on the correlation between Th1/Th2 responses may be related to differences between schistosome species or to antigens used and/or histories of infection in diverse epidemiological settings . However the differences may be a refection of the complexity of the relationship between cytokine data and infection intensity which goes beyond the Th1/Th2 dichotomy. We therefore investigated the relationship between the different cytokines (through correlation and data reduction methods) and used the results from a principal component analysis to relate infection intensity to the cytokine data after describing the epidemiology of the infection in the population.
Lyophilised soluble S. haematobium adult worm antigen (SWAP) was obtained from the Theodor Bilharz Institute (Egypt) and reconstituted as previously described elsewhere . The parasite strain is one used for previous immuno-epidemiology studies .
The study was conducted in the Mashonaland East Province of Zimbabwe (31°30'E; 17°45'S) where S. haematobium is endemic. The study area is described in detail elsewhere  and the participants have been participating in an ongoing study of the immunoepidemiology of human schistosomiasis [35, 37]. Permission to conduct the work in this province was obtained from the Provincial Medical Director (PMD) while ethical approval was received from the Medical Research Council of Zimbabwe. Following explanation of the study aims and procedures to the community, school children and their teachers, informed consent was obtained from participants or their parents/guardians. The villages were selected because health surveys regularly conducted in the region by the PMD showed little or no infection with other helminths and a low S. mansoni prevalence (<5%). Prior to our study the selected villages had not been included in the National Schistosome Control Programme (run by the Ministry of Health and Child Welfare in Zimbabwe) and therefore had not received treatment for schistosomiasis or other helminth infections meaning that we could study natural immune responses in the absence of drug-altered schistosome responses [12, 38]. The main activity in these villages is subsistence farming and human water contact is frequent with at least 4 contacts/person/week due to insufficient safe water and sanitation facilities (see  for studies in neighbouring villages). Drinking water is collected from open wells while bathing and washing is conducted in two main rivers in the villages. Most families maintain a garden located near the river where water is collected for watering the crops. The schools surveyed (a secondary school and its feeder primary school (i.e. where the majority of the primary school children come from) Goromonzi and Shangure Schools in Goromonzi Village, and Chindenga and Nyambanje Schools in Mutoko Village) were all in close proximity to rivers. Stool and urine specimens were assayed for S. haematobium, S. mansoni and geohelminths using standard procedures [39, 40]. In order to be included in the study, participants had to meet all the following criteria: 1) have provided at least 2 urine and 2 stool samples on consecutive days; 2) be negative for intestinal helminths including S. mansoni (no one was excluded on this criteria as everyone was negative for these infections), 3) have given a blood sample. 190 participants aged 6–40 years met these criteria and formed our study population. As is standard in all our studies after collection of all samples, all participants were offered treatment with the recommended dose of praziquantel (40 mg/kg of body weight).
Cytokine stimulations and assays
Whole blood stimulations were set up following a protocol developed at the University of Cambridge, UK . 10 mls of heparinised venous blood were collected and immediately diluted 1:4 in RPMI 1640 medium (Sigma) with penicillin (50 U/ml), streptomycin (50 μg/ml), L-glutamine (2 mM) (Sigma) and 10% AB serum. 250 μl of this media was added to a 48-well culture plate which already contained 25 μl of antigen in RPMI media described above at 10 μg/ml (SWAP, or Con A) or media alone. The study focused on responses against whole worm antigen to provide a complete picture of antibody and cellular responses against worm antigens (see [35, 37] presenting results of antibody responses of participants from this population).
Additional cultures were set up to detect the effect of neutralising IL-10 using samples from a subgroup of the participants who had provided enough blood to allow additional assays (n = 17, age range 6–17 years, mean infection intensity range 0–111 eggs/10 ml urine). For these cultures, 50 μl/well of 1 μg/ml anti-human IL-10 (rat IgG1 anti-human, JES3-9D7) antibody was added to half the plate before addition of the whole blood and 50 μl/well of 1 μg/ml isotype control (rat IgG1 R3-34) was added to the remaining half, so that the same sample was run on the same plate in wells containing anti-IL-10 antibody and the isotype control. The plates were placed in a glass jar, together with a gas generating kit (Oxoid) and incubated at 37°C for 48 hrs. Supernatants were harvested into cryotubes and stored at -20°C in the field prior to transportation at -20°C to the United Kingdom for analysis. Samples were thawed and all 4 cytokines assayed at the same time for each sample. IFN-γ, IL-4, IL-5, IL10 cytokine assays were conducted using capture ELISAs with antibody sets from BD Pharmigen following previously published protocols . All assays were conducted in duplicate.
Initial analyses were to determine the relationship between cytokine levels and infection intensity, as well as between cytokine pairs. After exploratory plots showed that these relationships were non linear and were directional (either positive or negative), the analyses were conducted using a one-tailed non parametric Spearman correlation procedure .
Description of study population
Age group (years)
Male (sample size)
Female (sample size)
Total (sample size)
Range of egg counts/10 ml urine
The next statistical tests were to determine the relationship of the cytokine responses (cumulatively) and infection status. This was achieved by factor analysis using principal components (PCA) . PCA is a standard technique for reducing multivariate data down to its main independent features . This procedure was used in this instance for two reasons (1) to avoid type I and type II errors in multiple tests using correlated independent variables [43, 44] and (2) to capture the effects of all cytokines in a single analysis since the responses are likely to be acting simultaneously (see ). Following the factor analysis principal components were analyzed further with logistic regression to determine the risk factors associated with being infected (egg positive) or uninfected (egg negative). Independent variables included the principal components, sex and age group (categorised as above).
The final statistical test was a two-tailed paired t-test to determine the effect of blocking IL-10 on cytokine levels conducted on the square root transformed cytokine data. All statistical tests were conducted using the software package SPSS. There is an outlier in the IL-4 data, therefore all statistical procedures were repeated with the single outlier removed; this did not affect the outcome of any of the statistical tests, so the results reported here include the outlier. All significant p values (<0.05) were subjected to Bonferoni testing .
Prevalence and intensity of infection
S. haematobium antigen specific cytokine responses – age profiles
Output of from the multi-variate analysis of variance conducted on all study participants
F = 1.532, df = 5,190, p = 0.182
F = 3.277, df = 5,190, p = 0.007
F = 4.875, df = 5,190, p < 0.001
F = 2.465, df = 5,190, p = 0.034
Single cytokine patterns with infection intensity
Relationships between cytokine pairs and between cytokines and infection intensity
Relationship between cytokine levels and infection status
Variance explained by the principal components extracted from the cytokine data.
Weighting (coefficient) of each cytokine in the values of the two principal components
Principal component 1
Principal component 2
Correlations between cytokines
Effect of blocking IL-10 on levels of IFN-γ, IL-4 and IL-5
Antibody to IL-10 was added to in vitro cultures during parasite antigen challenge. Blocking IL-10 in this way resulted in a significant change only in the level of parasite-specific IL-5, which increased from a mean of 5.15 ng/ml (SE = 1.39) in the control samples incubated in the presence of an isotype control to 6.56 ng/ml (SE 1.30) in the samples incubated in the presence of anti-IL-10 antibodies (T-Value = 3.12, df = 16, p = 0.007). IFN-γ and IL-4 production did not differ significantly between IL-10 blocked and normal control samples (T = 0.07, df = 16, p = 0.948; T = -0.62, df = 16, p = 0.542 respectively).
This study followed the development of naturally acquired schistosome-specific cytokine responses with host age to determine the rate of development of these responses. We have previously compared the same cytokine response across populations exposed to different infection intensities and showed that the rate of development of S. haematobium-specific cytokine responses was affected by the host's history of infection, with responses developing earlier in areas of high infection intensity compared to areas of low infection intensity . Here we compared the profiles of different cytokine responses within one host population. The cytokines studied were IFN-γ, a marker for Th1 responses, IL-4 and IL-5, markers for Th2 responses, and IL-10, originally classified as both a Th1 and Th2 cytokine in humans  but now also seen as a marker for immuno-modulatory responses including regulatory T cell responses [18, 20, 21].
In our study the different cytokines followed distinct age-profiles with the relationship between age and cytokine level being significant for IL-4 and IL-5 cytokines believed to be important in protection against re-infection with S. haematobium infection  as well as IL-10 which has previously been associated with immunomodulation. Levels of IL-10 response rose to peak early in childhood declining thereafter while levels of IL-4 and IL-5 rose more slowly to peak later with the peak in IL-4 being less pronounced than that of IL-5 so that the age groups where infection intensity and prevalence are lowest coincide with high IL-5 and low IL-10. Furthermore the study showed a positive correlation between IL-10 and infection intensity which both rose to peak in children aged 11–12 years and declined thereafter. The positive association of IL-10 and infection intensity has previously been reported in S. mansoni-exposed Brazilians . Two possible explanations for this positive association are, (1) IL-10 could simply be reflecting exposure to parasite antigens or (2), high levels of IL-10 are stimulated by high infection levels so as to prevent the development of excessive Th2-mediated pathology in addition to Th1-mediated pathology [14, 26]. The latter is consistent with earlier immuno-epidemiological studies of S. haematobium infection reporting immuno-suppression of schistosome responses in children [49, 50] and Th2 responses in adults with little or no infection . In the mouse model IL-10 reduces schistosome related liver damage and prolongs host survival , both of which are Th2-mediated, and in human S. haematobium and S. mansoni infections high IL-10 production has been associated with reduced schistosome-induced pathology(see  for review).
There was no correlation between infection intensity and either IL-4 or IL-5. A previous study in a S. mansoni endemic Ugandan fishing community suggested that high IL-5 levels are associated with low S. mansoni levels in older individuals since high levels coincided with the lowest infection levels . However, the Ugandan study showed no significant relationship between current infection intensity and IL-5 levels. This result is similar to our current observation that there was no significant correlation between these two parameters. Our study and that from the Ugandan fishing community support suggestions that IL-5-mediated responses against helminths may be directed against incoming parasites rather than existing worm burdens [51, 52]. This might also explain the lag between the age profiles of IL-5 levels and infection intensity we observed in this study.
When the relationship between all the cellular responses in our study was investigated by factor analysis, responses were divided into two principal components, i.e. IFN-γ/IL-4/IL-5 vs. IL-10 dichotomy rather than the more conventional Th1 vs. Th2 dichotomy [22, 48, 53]. Thus this analysis divided the cytokine responses into the Th1/Th2 effector responses and the immuno-modulatory IL-10 response. Further analysis of how this dichotomy related to infection level showed that while the relationship between the first component and infection level was unclear, people producing high levels of parasite-specific IL-10 (represented by the second PCA) being significantly more likely to be egg positive than those producing lower levels of the cytokine. These results suggest that the Th1/Th2 dichotomy may not sufficiently describe the development of resistance against schistosomiasis which, is consistent with previous schistosomiasis studies which have reported mixed Th1/Th2 responses against adult worm antigens  and current suggestions that the outcome of helminth infection is related to the balance between effector (Th1/Th2) and regulatory responses . The IL-10 response in this population was negatively correlated with the IL-5 response and blocking IL-10 resulted in an increase in parasite-specific IL-5 produced. Taken together these results support the proposition that in schistosomiasis at least, IL-10 is acting as a regulatory cytokine which inhibits a protective IL-5 dependent response [3, 17, 18, 55]. Various cells have been implicated in IL-10 production [26, 56] but the distinct cellular sources of this cytokine remain poorly defined in both human and experimental schistosomiasis. We are therefore currently determining the source of the parasite-specific IL-10 measured in this study.
Taken together, our results show first that the IL-10 response occurs early, peaking in young children, suggesting that immuno-modulatory responses are already present in the young age groups indicating a parallel to the mouse model of schistosomiasis in which IL-10 down-modulates the early phase of infection . Of course such parallels have to be interpreted with caution as human studies differ from experimental models in many respects not least by the lack of a precise measure of the point of infection in an endemic population and more so because of the potential for sensitisation to parasite antigens in utero [57, 58]. Second, our data indicate that IL-10 may be exerting its modulatory effect by down-regulating IL-5 production. More broadly our results also support current hypotheses suggesting that the balance between effector and immuno-modulatory responses is an important factor in the development of acquired resistance to schistosomes [26, 59].
We are grateful for the co-operation of the Ministry of Health and Child Welfare in Zimbabwe, the Provincial Medical Director of Mashonaland East, the Environmental Health Workers, residents, teachers and school children in Mutoko and Rusike. We also thank Frances Jones and David Dunne from the University of Cambridge, UK as well as Simon Babayan for advice on field and laboratory protocols. Munyaradzi Mapingure and members of the National Institutes of Health in Zimbabwe are also acknowledged for technical support. We acknowledge Alan Grafen, Dan Haydon Andrew Roddam and Mark Woolhouse for helpful discussion on the statistical analyses.
The investigation received financial support from the Medical Research Council, UK (Grant no G81/538), and the Carnegie Trust for the Universities of Scotland and the Wellcome Trust.
- Organisation WH: WHO technical report series, 2nd report:the control of schistosomiasis. Edited by: WHO . 1993, 3-Google Scholar
- Butterworth AE, Dunne DW, Fulford AJC, Thorne KJI, Gachuchi K, Ouma JM, Sturrock RF: Human immunity to Schistosoma mansoni: observations on mechanisms and implications for control. Immunological Investigations. 1992, 21: 391-407.View ArticlePubMedGoogle Scholar
- Correa-Oliveira R, Malaquias LC, Falcao PL, Viana IR, Bahia-Oliveira LM, Silveira AM, Fraga LA, Prata A, Coffman RL, Lambertucci JR, Cunha-Melo JR, Martins-Filho OA, Wilson RA, Gazzinelli G: Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection. Braz J Med Biol Res. 1998, 31: 171-177.View ArticlePubMedGoogle Scholar
- Dessein AJ, Begley M, Demeure C, Caillol A, Fueri O, dos Reis MG, Andrade ZA, Prata A, Bina JC: Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. The Journal of Immunology. 1988, 140: 2727-2736.PubMedGoogle Scholar
- Dunne DW, Butterworth AE, Fulford AJ, Ouma JH, Sturrock RF: Human IgE responses to Schistosoma mansoni and resistance to reinfection. Mem Inst Oswaldo Cruz. 1992, 87 (Suppl 4): 99-103.View ArticlePubMedGoogle Scholar
- King CH, el Ibiary S, el Nawawi M, Sawyer J, Griffin A, el Hawey A, Mahmoud AA: Intensity of Schistosoma mansoni infection in a human population is inversely correlated with antibody response to SmW68, a protective parasite antigen. J Infect Dis. 1989, 160: 686-691.View ArticlePubMedGoogle Scholar
- Woolhouse MEJ, Taylor P, Matanhire D, Chandiwana SK: Acquired immunity and epidemiology of Schistosoma haematobium. Nature. 1991, 351: 757-759.View ArticlePubMedGoogle Scholar
- Anderson RM: Determinants of infection in human schistosomiasis. Balliere's Clinical Tropical Medicine and Communicable Diseases. 1987, 2: 279-299.Google Scholar
- Woolhouse MEJ, Hagan P: Seeking the ghost of worms past. Nature Medicine. 1999, 5: 1225-1227.View ArticlePubMedGoogle Scholar
- Mutapi F, Hagan P, Ndhlovu P, Woolhouse MEJ: Comparison of humoral responses to Schistosoma haematobium in areas with high and low levels of infection. Parasite Immunology. 1997, 19: 255-263.View ArticlePubMedGoogle Scholar
- Hagan P, Blumenthal UJ, Dunne D, Simpson AJ, Wilkins HA: Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 1991, 349 (6306): 243-245.View ArticlePubMedGoogle Scholar
- Mutapi F, Ndhlovu PD, Hagan P, Spicer JT, Mduluza T, Turner CM, Chandiwana SK, J WME: Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. Journal of Infectious Diseases. 1998, 178: 289-293.View ArticlePubMedGoogle Scholar
- Stadecker MJ, Colley DG: The immunobiology of the schistosome egg granuloma. Parasitology Today. 1992, 8: 218-220.View ArticleGoogle Scholar
- Pearce EJ, MacDonald AS: The immunobiology of schistosomiasis. Nat Rev Immunol. 2002, 2: 499-511.View ArticlePubMedGoogle Scholar
- Hoffmann KF, Wynn TA, Dunne DW: Cytokine-mediated host responses during schistosome infections; walking the fine line between immunological control and immunopathology. Adv Parasitol. 2002, 52: 265-307.View ArticlePubMedGoogle Scholar
- Cheever AW, Hoffmann KF, Wynn TA: Immunopathology of schistosomiasis mansoni in mice and men. Immunol Today. 2000, 21: 465-466.View ArticlePubMedGoogle Scholar
- Abath FG, Morais CN, Montenegro CE, Wynn TA, Montenegro SM: Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies?. Trends Parasitol. 2006, 22: 85-91.View ArticlePubMedGoogle Scholar
- Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA: The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol. 2004, 172: 3157-3166.View ArticlePubMedGoogle Scholar
- Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S: Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol. 1993, 150: 353-360.PubMedGoogle Scholar
- van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, Yazdanbakhsh M: Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet. 2000, 356: 1723-1727.View ArticlePubMedGoogle Scholar
- McKee AS, Pearce EJ: CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol. 2004, 173: 1224-1231.View ArticlePubMedGoogle Scholar
- Medhat A, Shehata M, Bucci K, Mohamed S, Dief AD, Badary S, Galal H, Nafeh M, King CL: Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis. 1998, 178: 512-519.View ArticlePubMedGoogle Scholar
- Wilson AA: Immunity and immunoregulation in helminth infections. Current Opinion in Immunology. 1993, 5: 538-547.View ArticlePubMedGoogle Scholar
- Capron A, Dombrowicz D, Capron M: Regulation of the immune response in experimental and human schistosomiasis: the limits of an attractive paradigm. Microbes Infect. 1999, 1 (7): 485-490.View ArticlePubMedGoogle Scholar
- Dunne DW, Mountford AP: Resistance to infection in human and animal models. Schistosomiasis. Edited by: Mahmoud AAF. 2001, London, Imperial College PressGoogle Scholar
- Taylor JJ, Mohrs M, Pearce EJ: Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol. 2006, 176: 5839-5847.View ArticlePubMedGoogle Scholar
- Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA: Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology. 2006, 117: 433-442.View ArticlePubMedPubMed CentralGoogle Scholar
- Satapathy AK, Sartono E, Sahoo PK, Dentener MA, Michael E, Yazdanbakhsh M, Ravindran B: Human bancroftian filariasis: immunological markers of morbidity and infection. Microbes Infect. 2006, 8: 2414-2423.View ArticlePubMedGoogle Scholar
- Hubner MP, Manfras BJ, Margos MC, Eiffler D, Hoffmann WH, Schulz-Key H, Kern P, Soboslay PT: Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients. Clin Exp Immunol. 2006, 145: 243-251.View ArticlePubMedPubMed CentralGoogle Scholar
- Beiting DP, Gagliardo LF, Hesse M, Bliss SK, Meskill D, Appleton JA: Coordinated control of immunity to muscle stage Trichinella spiralis by IL-10, regulatory T cells, and TGF-beta. J Immunol. 2007, 178: 1039-1047.View ArticlePubMedGoogle Scholar
- Wynn TA, Hoffmann KF: Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2?. Parasitol Today. 2000, 16: 497-501.View ArticlePubMedGoogle Scholar
- Scott JT, Turner CM, Mutapi F, Woolhouse ME, Ndhlovu PD, Hagan P: Cytokine responses to mitogen and Schistosoma haematobium antigens are different in children with distinct infection histories. Parasite Immunol. 2001, 23: 519-526.View ArticlePubMedGoogle Scholar
- Scott JT: Dissociation of interleukin-4 and interleukin-5 production following treatment for Schistosoma haematobium infection in humans. Parasite Immunology. 2000, 22: 341-348.View ArticlePubMedGoogle Scholar
- Silveira AM, Gazzinelli G, Alves-Oliveira LF, Bethony J, Gazzinelli A, Carvalho-Queiroz C, Alvarez MC, Lima-Silva FC, Prata A, LoVerde PT, Correa-Oliveira R: Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferon-gamma and interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures. Trans R Soc Trop Med Hyg. 2004, 98: 514-519.View ArticlePubMedGoogle Scholar
- Mutapi F, Burchmore R, Foucher A, Harcus Y, Nicoll G, Midzi N, Turner CM, Maizels R: Praziquantel treatment of people exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. Journal of Infectious Diseases. 2005, 192: 1108-1118.View ArticlePubMedGoogle Scholar
- Ndhlovu P, Cadman H, Vennervald BJ, Christensen NO, Chidimu N, Chandiwana SK: Age-related antibody profiles in Schistosoma haematobium in a rural community in Zimbabwe. Parasite Immunology. 1996, 18: 181-191.View ArticlePubMedGoogle Scholar
- Mutapi F, Mduluza T, Gomez-Escobar N, Gregory WF, Fernandez C, Midzi N, Maizels RM: Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden. BMC Infect Dis. 2006, 6: 96-View ArticlePubMedPubMed CentralGoogle Scholar
- Correa-Oliveira R, Caldas RI, Gazzinelli G: Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitology Today. 2000Google Scholar
- Katz N, Chaves A, Pellegrino J: A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Revista do Instituto de Medicina Tropical de Sao Paulo. 1972, 14: 397-400.PubMedGoogle Scholar
- Mott KE: A reusable polyamide filter for diagnosis of S. haematobium infection by urine filtration. Bull Soc Pathol Exot Filiales. 1983, 76 (1): 101-104.PubMedGoogle Scholar
- Joseph S, Jones FM, Kimani G, Mwatha JK, Kamau T, Kazibwe F, Kemijumbi J, Kabatereine NB, Booth M, Kariuki HC, Ouma JH, Vennervald BJ, Dunne DW: Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens. Infect Immun. 2004, 72: 728-734.View ArticlePubMedPubMed CentralGoogle Scholar
- Sokal RR, Rohlf J: Biometry: the principles and practice of statistics in biological research. 1995, , Freeman and CompanyGoogle Scholar
- Mutapi F, Roddam A: p-values for pathogens: statistical inference from infectious-disease data. Lancet Infect Dis. 2002, 2 (4): 219-230.View ArticlePubMedGoogle Scholar
- Grafen A, RHails R: Modern statistics for the life sciences. 2002, , Oxford Univeristy PressGoogle Scholar
- Mutapi F, Mduluza T, Roddam AW: Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups. Immunol Lett. 2005, 96: 231-240.View ArticlePubMedGoogle Scholar
- Rice WR: Analysing tables of statistical tests. Evolution. 1989, 43: 223-225.View ArticleGoogle Scholar
- Montresor A, Crompton DWT, Bundy DAP, Hall A, Savioli L: Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level. 1998, Geneva, World health OrganisationGoogle Scholar
- Mduluza T, Ndhlovu PD, Midzi N, Scott JT, Mutapi F, Mary C, Couissinier-Paris P, Turner CM, Chandiwana SK, Woolhouse ME, Dessein AJ, Hagan P: Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe. Immunol Lett. 2003, 88: 249-256.View ArticlePubMedGoogle Scholar
- Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M: Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis. 1998, 177: 1433-1437.View ArticlePubMedGoogle Scholar
- Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M: The effect of anti-IL-10 on proliferation and cytokine production in human schistosomiasis: fresh versus cryopreserved cells. Parasite Immunol. 1998, 20: 345-349.View ArticlePubMedGoogle Scholar
- Maizels RM, Balic A: Resistance to helminth infection: the case for interleukin-5-dependent mechanisms. J Infect Dis. 2004, 190: 427-429.View ArticlePubMedGoogle Scholar
- Quinnell RJ, Pritchard DI, Raiko A, Brown AP, Shaw MA: Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection. J Infect Dis. 2004, 190: 430-438.View ArticlePubMedGoogle Scholar
- Turner JD, Faulkner H, Kamgno J, Cormont F, Van Snick J, Else KJ, Grencis RK, Behnke JM, Boussinesq M, Bradley JE: Th2 cytokines are associated with reduced worm burdens in a human intestinal helminth infection. J Infect Dis. 2003, 188: 1768-1775.View ArticlePubMedGoogle Scholar
- Taylor MD, LeGoff L, Harris A, Malone E, Allen JE, Maizels RM: Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol. 2005, 174: 4924-4933.View ArticlePubMedGoogle Scholar
- Araujo MI, Hoppe BS, Medeiros M, Carvalho EM: Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases. Mem Inst Oswaldo Cruz. 2004, 99: 27-32.View ArticlePubMedGoogle Scholar
- Baumgart M, Tompkins F, Leng J, Hesse M: Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol. 2006, 176: 5374-5387.View ArticlePubMedGoogle Scholar
- King CL, Malhotra I, Mungai P, Wamachi A, Kioko J, Ouma JH, Kazura JW: B cell sensitization to helminthic infection develops in utero in humans. J Immunol. 1998, 160: 3578-3584.PubMedGoogle Scholar
- Malhotra T, Mungai P, Wamachi A, Kioko J, Ouma JH, Kazura JW, King LK: Helmnth and Bacillus Calmette-Guerin -induced immunity in children sensitized in utero to filariasis and schistosomiasis. The Journal of Immunology. 1999, 162: 6843-6848.PubMedGoogle Scholar
- Maizels RM, Yazdanbakhsh M: Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003, 3: 733-744.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/7/139/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.